Menlo Park, CA, United States of America

Transvascular, Inc.


USPTO Granted Patents = 35

% Expired Patents = 2.9


Forward Citations = 18,986

Loading Chart...
Loading Chart...

36 inventors (with patents filed for the assignee):

goldMedal Joshua Makower (27 out of 279 patents)

silverMedal J Christopher Flaherty (22 out of 267 patents)

bronzeMedal Jason Brian Whitt (16 out of 36 patents)

4.  John T Garibotto (11 out of 45 patents)

5.  Philip Christopher Evard (11 out of 46 patents)

6.  Timothy R Machold (8 out of 139 patents)

7.  Patrick Edward Macaulay (6 out of 52 patents)

8.  David R Tholfsen (4 out of 27 patents)

9.  John Y Chang (4 out of 150 patents)

10.  Steven W Kim (4 out of 42 patents)

11.  Theodore Charles Lamson (3 out of 94 patents)

12.  Robert S Schwartz (2 out of 161 patents)

13.  Ascher Shmulewitz (2 out of 38 patents)

14.  David R Holmes, Iii (2 out of 48 patents)

15.  Thomas Banks (2 out of 17 patents)


Core Competencies:
Transvascular
Catheter
Drug Delivery
Arterial Bypass
Tissue Penetration
Interventional Devices
Anatomical Conduits
Myocardial Perfusion
Stenting
Fluid Connection
Guidewire
Scaffolding

35 patents:

Transvascular, Inc. is a pioneering medical technology company based in Menlo Park, California, specializing in the development of innovative solutions for vascular access and intervention. The organization focuses on enhancing patient outcomes through advanced medical devices and technologies that facilitate minimally invasive procedures. With a commitment to research and development, Transvascular aims to address critical challenges in the healthcare sector, particularly in the fields of interventional cardiology and vascular surgery.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

35 Patents

#45 in Menlo Park, CA

#2,306 in California

#9,740 in US

#19,148 in the World

Menlo Park, CA (US)
Menlo Park, CA, United States of America
Forward Citations = 18,986

36 inventors:

Please report any incorrect information to [email protected]
Loading…